Y0002055

Fingolimod hydrochloride

European Pharmacopoeia (EP) Reference Standard

• Synonim(y): FTY720, 2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol hydrochloride, Fingolimod hydrochloride
• Wzór empiryczny (zapis Hilla): C₁₉H₃₃NO₂ · HCl
• Numer CAS: 162359-56-0
• Masa cząsteczkowa: 343.93
• Kod UNSPSC: 41116107
• NACRES: NA.24

Właściwości

• pochodzenie biologiczne: synthetic
• klasa czystości: pharmaceutical primary standard
• agency: EP
• rodzina API: fingolimod
• Formularz: powder
• opakowanie: pkg of 110 mg
• producent / nazwa handlowa: EDQM
• warunki przechowywania: protect from light
• rozpuszczalność: water: 100-1000 g/L
• Zastosowanie: pharmaceutical
• Format: neat
• Warunki transportu: ambient
• temp. przechowywania: 2-8°C
• ciąg SMILES: Cl.NC(CO)(CO)CCc1ccc(cc1)CCCCCCCC
• InChI: 1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H
• Klucz InChI: SWZTYAVBMYWFGS-UHFFFAOYSA-N

Opis

Opis ogólny

Fingolimod Hydrochloride (fingolimod HCl), an S1P-receptor modulator, belongs to the class of synthetic glucocorticoid steroid drugs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Zastosowanie

This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.

Działania biochem./fizjol.

FTY720 is an immunomodulating drug and sphingosine 1-phosphate (S1P) receptor modulator. Phosphorylation of FTY270 by sphingosine kinase causes S1P1R internalization, which sequesters lymphocytes in lymph nodes, preventing them from taking part in an autoimmune response. Clinically, it has been approved for the treatment of multiple sclerosis (MS). It has also been shown to block and reverse paclitaxel-induced chemotherapy induced peripheral neuropathy (CIPN) through S1PR inhibition as well as inhibit the activity of histone deacetylases in the hippocampus of mouse brains, thereby modulating memory.

FTY720, an immunomodulating drug, acts as a sphingosine 1-phosphate (S1P) receptor modulator.

Opakowanie

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Inne uwagi

Sales restrictions may apply.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS08
• Hasło ostrzegawcze: Warning
• Zwroty wskazujące rodzaj zagrożenia: H373
• Zwroty wskazujące środki ostrożności: P260 - P314 - P501
• Klasyfikacja zagrożeń: STOT RE 2
• Organy docelowe: Immune system
• Kod klasy składowania: 11 - Combustible Solids
• Klasa zagrożenia wodnego (WGK): WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable